Investing in an Indian startup as an NRI: repatriable or not is the choice that matters.

Yes, and it is more straightforward than it used to be. An NRI can buy equity in an Indian startup or an unlisted private company, and the law treats it as foreign direct investment, permitted in most sectors under the automatic route with no prior approval, though a handful of sectors are barred or need government clearance. Whether you are writing an angel cheque into a friend's company or putting money into a growth-stage private business, the basic ability to invest is not in doubt.

The choice that actually matters is not whether you can invest, but how you fund it. You can invest on a repatriable basis, using money from your NRE or FCNR account, or on a non-repatriable basis, using your NRO account. Both are entirely legal routes, and they look identical on the day you invest. They diverge completely at the exit, because only one of them lets you freely take the proceeds back abroad.

So the single most important decision is made at the start, quietly, in which account the money comes from. Get that right for your plan and the rest is administration; get it wrong and you can find your exit money trapped in India. The sections below cover that fork, the now-abolished angel tax that used to complicate the entry, the valuation rule, and the tax when you eventually sell.

For years the entry into an Indian startup carried a peculiar risk called angel tax. Under Section 56(2)(viib), if a company issued shares to an investor at a price above their fair market value, the excess was taxed in the company's hands as income, which made pricing a funding round unexpectedly dangerous, especially for early-stage startups whose value is a matter of judgement.

That is over. Angel tax is abolished with effect from assessment year 2025-26, which means any share issue from 1 April 2024 is free of it, for every class of investor. The point matters specifically for NRIs because of a short, alarming detour: the 2023 Budget pulled non-resident investors into the tax for issues from 1 April 2023, bringing foreign investment squarely within its reach, before the very next Budget reversed course and scrapped the tax for everyone. So the position now is clean, any round from 1 April 2024 carries no angel tax at all, and only a round funded before that date, in financial year 2023-24 or earlier, can still in principle attract a legacy demand.

For you as an investor, the practical effect is freedom on price. You can pay a premium that reflects what you think the company is worth without triggering a tax on the company for doing so. The valuation rule below still sets a floor you cannot go under, but the ceiling that angel tax used to impose is gone.

This is the decision to make consciously, because it is easy to make by accident simply by paying from whichever account is handy. Investing on a repatriable basis means funding the purchase from your NRE or FCNR account. Your capital and your gains can then be remitted out of India after you have paid the tax due, so your exit money can follow you abroad.

Investing on a non-repatriable basis means funding it from your NRO account, under what is known as the Schedule 4 route. Here the investment is treated on par with a resident Indian's, which has its own conveniences, but the returns are taxable in India and can only be taken abroad within the general USD 1 million per financial year limit that applies to NRO funds. For a small investment that may never matter; for a large one that exits into a big gain, it can be the difference between repatriating freely and rationing the remittance over years.

Neither route is right or wrong in the abstract; the right one depends on what you intend to do with the proceeds. If the money is long-term India-committed, non-repatriable can be simpler. If you expect to want the exit abroad, fund it from NRE or FCNR so the repatriable status is baked in from day one. What you should not do is decide by default, because changing the character of the holding later is far harder than choosing correctly at the start.

Some of the paperwork depends on which route you chose, and it protects your holding, so it is worth confirming it happens. On the repatriable route, when the company allots you the shares it must file Form FC-GPR with the RBI through its bank within 30 days, and it files an annual Foreign Liabilities and Assets return; a company that skips these leaves your holding technically non-compliant under FEMA, which can complicate your exit, so a quick check is time well spent. The non-repatriable Schedule 4 route needs neither, because it is treated as a domestic investment. Separately, when shares are transferred a Form FC-TRS is filed within 60 days, and on your exit sale that filing falls to the resident party to the deal, not to you or the company.

There is also a floor on price, again on the repatriable route. Because that is foreign investment, the shares must be issued to you at or above their fair market value, certified by a chartered accountant, a SEBI-registered merchant banker or a practising cost accountant using an internationally accepted method such as discounted cash flow or net asset value. With angel tax gone, paying above that floor no longer costs the company anything in tax, but on the repatriable route you cannot come in below it. The non-repatriable route, treated as domestic, does not carry this FEMA pricing floor.

Then there is your own tax, which arrives at the exit. When you sell unlisted shares, a holding of more than 24 months is long-term, taxed for an NRI at 12.5% without indexation; a shorter holding is short-term at your slab rate. As an NRI you do not get the basic-exemption cushion a resident might set against the gain, and the buyer may need to deduct TDS under Section 195, which a lower-deduction certificate can size correctly so tax is not withheld on the whole sale value. The exit tax is covered in full in our page on selling unlisted and startup shares as an NRI; the key point here is that the gain, and how freely its proceeds leave India, both trace back to the repatriable choice you made when you first invested.